These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33470139)

  • 1. Cenobamate tablets as a treatment for focal-onset seizures in adults.
    Steinhoff BJ
    Expert Rev Clin Pharmacol; 2021 Feb; 14(2):161-172. PubMed ID: 33470139
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
    Wheless JW
    Expert Rev Neurother; 2020 Nov; 20(11):1085-1098. PubMed ID: 33031714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.
    Lattanzi S; Trinka E; Zaccara G; Striano P; Del Giovane C; Silvestrini M; Brigo F
    CNS Drugs; 2020 Nov; 34(11):1105-1120. PubMed ID: 32851590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability.
    Roberti R; De Caro C; Iannone LF; Zaccara G; Lattanzi S; Russo E
    CNS Drugs; 2021 Jun; 35(6):609-618. PubMed ID: 33993416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cenobamate for the treatment of focal epilepsies.
    Strzelczyk A; Mann C; Willems LM; Rosenow F; Bauer S
    Expert Opin Pharmacother; 2020 Dec; 21(18):2215-2223. PubMed ID: 32812825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
    Sperling MR; Klein P; Aboumatar S; Gelfand M; Halford JJ; Krauss GL; Rosenfeld WE; Vossler DG; Wechsler R; Borchert L; Kamin M
    Epilepsia; 2020 Jun; 61(6):1099-1108. PubMed ID: 32396252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
    Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
    Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study.
    Winter Y; Abou Dargham R; Patiño Tobón S; Groppa S; Fuest S
    CNS Drugs; 2024 Sep; 38(9):733-742. PubMed ID: 39096467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cenobamate: A New Adjunctive Agent for Drug-Resistant Focal Onset Epilepsy.
    Buckley CT; Waters OR; DeMaagd G
    Ann Pharmacother; 2021 Mar; 55(3):318-329. PubMed ID: 32623899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical guidance for the management of adults receiving adjunctive cenobamate for the treatment of focal epilepsy-expert opinion.
    Steinhoff BJ; Rosenfeld WE; Serratosa JM; Brandt C; Klein P; Toledo M; Krauss GL
    Epilepsy Behav; 2021 Oct; 123():108270. PubMed ID: 34509033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset of efficacy and adverse events during Cenobamate titration period.
    Steinhoff BJ; Ben-Menachem E; Brandt C; García Morales I; Rosenfeld WE; Santamarina E; Serratosa JM
    Acta Neurol Scand; 2022 Sep; 146(3):265-275. PubMed ID: 35711112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
    Zhang L; Wang J; Wang C
    Acta Neurol Scand; 2021 Jul; 144(1):58-66. PubMed ID: 33788253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Treatment for Partial-Onset Seizures in Adults.
    Aschenbrenner DS
    Am J Nurs; 2020 Mar; 120(3):24-25. PubMed ID: 32079793
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study.
    O'Dwyer R; Stern S; Wade CT; Guggilam A; Rosenfeld WE
    Drugs Aging; 2024 Mar; 41(3):251-260. PubMed ID: 38446341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cenobamate for the treatment of focal epilepsy.
    Dhir A
    Drugs Today (Barc); 2020 Apr; 56(4):233-240. PubMed ID: 32309819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures.
    Chung SS; French JA; Kowalski J; Krauss GL; Lee SK; Maciejowski M; Rosenfeld WE; Sperling MR; Mizne S; Kamin M
    Neurology; 2020 Jun; 94(22):e2311-e2322. PubMed ID: 32409485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cenobamate with other newer antiseizure medications for adjunctive treatment of focal-onset seizures: A systematic review and network meta-analysis.
    Mulheron S; Leahy TP; McStravick M; Doran R; Delanty N
    Seizure; 2024 May; 118():80-90. PubMed ID: 38643679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending-Dose Studies in Healthy Subjects.
    Vernillet L; Greene SA; Kamin M
    Clin Pharmacol Drug Dev; 2020 May; 9(4):428-443. PubMed ID: 32087001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
    Rosenfeld WE; Nisman A; Ferrari L
    Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
    Krauss GL; Klein P; Brandt C; Lee SK; Milanov I; Milovanovic M; Steinhoff BJ; Kamin M
    Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.